Consolidation • Renewable Energy

Qualitas Equity Acquires Nclave

On March 1, 2017, asset manager Qualitas Equity acquired renewable energy company Nclave

Acquisition Context
  • This is Qualitas Equity’s 2nd transaction in the Renewable Energy sector.
  • This is Qualitas Equity’s 9th transaction in Spain.
Investment Fate
  • Nclave was sold to a strategic buyer in 2018.

Explore All 33 Consolidation Renewable Energy Deals - Search the Database Free


M&A Deal Summary

Date March 1, 2017
Target Nclave
Sector Renewable Energy
Buyer(s) Qualitas Equity
Deal Type Consolidation

Target Company

Nclave

Madrid, Spain
Nclave is a designer, manufacturer, installation and maintenance of solar trackers and fixed-tilt structures worldwide. Nclave was founded in 2017 and is based in Madrid, Spain.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

DESCRIPTION

Qualitas Equity is a private equity firm that seeks investments in middle-market Spanish and Portuguese companies. Qualitas seeks control investments in marketing, food, manufacturing, and service based businesses. Qualitas looks to invest in buyout and growth capital transactions requiring €4 to €15 million of equity capital. The Firm's investment horizon is three to seven years. Qualitas Equity was formed in 2003 and is based in Madrid.


Deal Context for Buyer #
Overall 9 of 11
Sector: Renewable Energy 2 of 2
Type: Consolidation 1 of 1
Country: Spain 9 of 10
Year: 2017 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-11 Salupro

Madrid, Spain

Salupro is a digital purchasing center specialized in the distribution of dental and veterinary equipment. Salupro was founded in 2011 and is based in Madrid, Spain.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-03-24 imegen

Valencia, Spain

imegen is a genetic diagnosis and genomics specialist firm, an internationally respected genetic analysis laboratory with a strong commitment to R&D and to collaborate intensively in medical training and popular science. imegen was founded in 2009 and is based in Valencia, Spain.

Buy -

Explore Related M&A Activity